421 related articles for article (PubMed ID: 34532773)
41. Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Tolosa E; Valldeoriola F; Marti MJ
J Neural Transm Suppl; 1994; 42():15-31. PubMed ID: 7964684
[TBL] [Abstract][Full Text] [Related]
42. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
Williams DR; Lees AJ
Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
[TBL] [Abstract][Full Text] [Related]
43. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
Talai AS; Sedlacik J; Boelmans K; Forkert ND
Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
[TBL] [Abstract][Full Text] [Related]
44. Differentiating progressive supranuclear palsy from other movement disorders using transcranial sonography: a systematic review and meta-analysis.
Wen Y; Zhou H; Xia M; Liu Q; Quan H; Fang L
Neurol Sci; 2024 Feb; 45(2):455-465. PubMed ID: 37819487
[TBL] [Abstract][Full Text] [Related]
45. Progressive Supranuclear Palsy and Corticobasal Syndrome.
Pantelyat A
Continuum (Minneap Minn); 2022 Oct; 28(5):1364-1378. PubMed ID: 36222770
[TBL] [Abstract][Full Text] [Related]
46. Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson's disease.
Sung YH; Kang SY
Neurol Sci; 2022 Aug; 43(8):4797-4802. PubMed ID: 35347528
[TBL] [Abstract][Full Text] [Related]
47. Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
Choi JH; Kim H; Shin JH; Lee JY; Kim HJ; Kim JM; Jeon B
J Neurol; 2021 Mar; 268(3):967-977. PubMed ID: 32959131
[TBL] [Abstract][Full Text] [Related]
48. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J
Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686
[TBL] [Abstract][Full Text] [Related]
49. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
Shill HA; Zhang N; Driver-Dunckley E; Mehta S; Adler CH; Beach TG
Mov Disord; 2021 Jul; 36(7):1700-1704. PubMed ID: 33755262
[TBL] [Abstract][Full Text] [Related]
50. Natural history and clinical features of progressive supranuclear palsy: a clinical study.
Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G
Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074
[TBL] [Abstract][Full Text] [Related]
51. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
Pinkhardt EH; Jürgens R; Becker W; Valdarno F; Ludolph AC; Kassubek J
J Neurol; 2008 Dec; 255(12):1916-25. PubMed ID: 19224319
[TBL] [Abstract][Full Text] [Related]
52. Presence of Skin α-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome.
Giannoccaro MP; Avoni P; Rizzo G; Incensi A; Infante R; Donadio V; Liguori R
J Parkinsons Dis; 2022; 12(2):585-591. PubMed ID: 34864689
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis across a cohort of "atypical" atypical and complex parkinsonism.
Malaquias MJ; Igreja L; Nogueira C; Pereira C; Vilarinho L; Quelhas D; Freixo JP; Oliveira J; Magalhães M
Parkinsonism Relat Disord; 2023 Jun; 111():105408. PubMed ID: 37105015
[TBL] [Abstract][Full Text] [Related]
54. Instability of syllable repetition in progressive supranuclear palsy.
Skodda S; Grönheit W; Schlegel U
J Neural Transm (Vienna); 2012 Apr; 119(4):457-62. PubMed ID: 22065210
[TBL] [Abstract][Full Text] [Related]
55. [Progressive supranuclear palsy: what's new?].
Levy R
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
[TBL] [Abstract][Full Text] [Related]
56. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
57. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
58. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
Tommasini L; Bonaccorsi J; Del Prete E; Cintoli S; Pagni C; Mazzucchi S; Palermo G; Morganti R; Frosini D; Siciliano G; Tognoni G; Ceravolo R
Clin Neuropsychol; 2023 Aug; 37(6):1207-1220. PubMed ID: 35997036
[No Abstract] [Full Text] [Related]
59. Parkinsonism: heterogeneity of a common neurological syndrome.
Bohlhalter S; Kaegi G
Swiss Med Wkly; 2011; 141():w13293. PubMed ID: 22052571
[TBL] [Abstract][Full Text] [Related]
60. Discriminating features of gait performance in progressive supranuclear palsy.
Amano S; Skinner JW; Lee HK; Stegemöller EL; Hack N; Akbar U; Vaillancourt D; McFarland NR; Hass CJ
Parkinsonism Relat Disord; 2015 Aug; 21(8):888-93. PubMed ID: 26032992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
